tenk.fyi

KalVista Pharmaceuticals, Inc.

KALVNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$183.4M

44.9% YoY

EPS

$-3.69

7.3% YoY

Cash

$131.6M

314.0% YoY

FY 2025 · As of 2025-04-30

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro